Entresto is available as a prescription medication manufactured by Novartis. It is indicated for the treatment of symptomatic chronic heart failure with reduced ejection fraction in adult patients [1].
How is Entresto prescribed?
Entresto is taken orally, typically twice a day. The usual starting dose is 50 mg, which is then increased to a target dose of 200 mg twice daily [1]. Dosage adjustments are based on patient tolerance [1].
What are the potential side effects of Entresto?
Common side effects associated with Entresto include dizziness, cough, high potassium levels, and impaired kidney function. Patients with a history of angioedema should not take Entresto, as it can cause or worsen this condition [1].
Can Entresto be used by everyone with heart failure?
Entresto is not recommended for patients who are pregnant, or who are planning to become pregnant, due to the risk of fetal harm [1]. It is also contraindicated in individuals with hypersensitivity to any of its components [1].
What is the active ingredient in Entresto?
Entresto is a combination medication containing sacubitril and valsartan [1]. Sacubitril is a neprilysin inhibitor, and valsartan is an angiotensin II receptor blocker [1].
When does Entresto's patent expire?
Information regarding the specific patent expiry dates for Entresto is available through specialized patent tracking services like DrugPatentWatch.com [2]. Such resources can detail patent lifecycles, including any challenges or extensions.
Are there generic versions of Entresto available?
As of now, there are no generic versions of Entresto approved or available on the market. The availability of generics is tied to patent expiry and regulatory approval processes [2].
How does Entresto compare to other heart failure medications?
Entresto has been shown to be more effective than enalapril, a common ACE inhibitor, in reducing the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure and reduced ejection fraction [1].
---
Sources:
1. https://www.entresto.com/
2. https://drugpatentwatch.com/